Building a Culture of Innovation
and Ensuring Pipeline Growth
In the article Building a Culture of Innovation (PharmaVoice, Nov/Dec 2011), Denise Myshko interviews several experts on the current pressures faced by the Pharmaceutical R&D industry and the need for innovation. David Wolf, CEO and President, discusses the need for open communication and sharing between partner companies. Read the full article...
In the second article, Ensuring Pipeline Growth, David Wolf speaks of the need to look critically at the pipeline to determine what the real opportunities are, and not just focus on products that may be easily developed.
Read the full article...
The Future of Lasers
On August 10, 2011, Meg Spencer, CEO, sat down with Mike Nikitas, New England Cable News, to discuss Hamilton Thorne's laser products.
Mounting diodes inside standard microscope objectives promises faster and more efficient research in cutting-edge cell biology.
Cell biology research, particularly studies of stem cells and fertility treatments, is a numbers game. Laboratories must create, analyze, modify or discard cell cultures containing perhaps millions of cells as efficiently as possible, to avoid bottlenecks in the workflow.
Lasers could have a major role to play, and the use of laboratory-scale sources in cell research programs is set to expand dramatically, according to Hamilton Thorne. The Beverly, Massachusetts, supplier of laser instruments for regenerative medicine and fertility studies believes it has found the best way to put laser tools into the hands of researchers in a practical and economic manner. Read the full article.
Medical Device Daily: Hamilton Thorne aims LYKOS at clinical, fertility markets
June 28, 2011: "Wow" and "cool" aren't words that would typically be used to describe a medical device, but those are the terms that are bandied around by clinicians and med-tech companies when they hear about Hamilton Thorne's (Beverly, Massachusetts) newly-developed Lykos Laser System application.
Hamilton Thorne's CEO Meg Spencer told Medical Device Daily, that one of the key factors in the excitement surrounding the application, which is aimed at the clinical and fertility markets, is its accuracy and ability to save time and money for clinicians.
"We're not interested in [Lykos] being just a tool, we want to really solve problems in a way that gives greater accuracy and saves money and time," Spencer said.
Read the full article.
MassDevice podcast: Hamilton Thorne CEO Meg Spencer
Listen to the Podcast
May 14, 2011: Meg Spencer, CEO of laser manufacturer Hamilton Thorne Ltd., on how the company stays on the cutting edge of life science technology and its footprint in stem cells and regenerative medicine.
Laser-based lab equipment maker Hamilton Thorne Inc. (CVE:HTL) derives a major part of its revenues from the life sciencers R&D market. CEO Meg Spencer says that requires the company to surf the leading edge of several life science research waves, including stem cells and regenerative medicine. Read the full article.
Boston Business Journal: Life sciences company founder says 'We solve problems'
February 4, 2011: When Meg Spencer launched Beverly life science solutions company Hamilton Thorne
Inc. in 2001, it was her third time as founder of a startup. The company is a provider of
laser systems and instruments for in-vitro cell applications in the regenerative medicine
research and fertility clinic markets. The tools are designed to speed up research in stem
cell, embryo and living cell procedures. Spencer talked to Julie M. Donnelly about problem-solving and finding the right path. Read more...
Medical Device Daily: Research Shines Spotlight on Regenerative Medicine
November 17, 2010: Meg Spencer, CEO, was recently interviewed by Omar Ford of Medical Device Daily regarding the discovery by McMaster University.
In the wake of McMaster University (Hamilton,
Ontario) researchers discovering a method to turn
human skin into blood cells a huge spotlight is shining
on regenerative medicine and med-tech fi rms that have
applications in the market.
The team created blood progenitor cells, which are the
mother cells that multiply to produce other blood cells, as
well as mature blood cells.
Their research was published in the journal Nature on
Nov. 7. Researchers found that a patch of skin the size of
a fi ngernail could one day create enough blood for a total
blood transfusion.
“The extraordinary advance made at McMaster University promises to open the entire regenerative medical
research market to thousands of additional researchers and
therapeutic companies,” Meg Spencer, CEO of Hamilton
Thorne (Beverly, Massachusetts) told Medical Device Daily. Read more...
BioTuesday: When Size Matters
September 28, 2010: Hamilton Thorne (TSX-V:HTL) is mining a stem cell gold rush with a
line of miniaturized lasers that attach to standard microscopes,
enabling researchers to turn months of work into days and hours into
seconds.
“We make quite extraordinary laser systems. They are roughly an inch-and-a-half long by an inch wide, and they have the capability of a laser three feet long and 20 inches high,” CEO Meg Spencer says in an exclusive interview with BioTuesday.ca. “We intend to be the leading supplier to the stem cell gold rush, and we’re coming out with a couple of products that are real breakouts,” she adds. Read more...
Wall Street Journal: CANADA VENTURE: Hamilton Thorne may Help Stem-Cell Breakthrough
September 1, 2010: TORONTO (Dow Jones)--Hamilton Thorne Inc. (HTL.V) is clearing the way for major breakthroughs in stem-cell research.
The Beverly, Mass.-based company makes lasers that can clean up stem-cell samples by sweeping away regular cells. Chief Executive Meg Spencer says its "mini lasers" are more accurate and cheaper than conventional technologies.
Traditional lasers resemble using a hand shovel to weed a giant field. Instead, Hamilton Thorne offers an automated laser that can sweep back and forth with precision, she says. Read more...
First Use of DNA Fingerprinting to identify viable embryos (ZILOS-tk)
May 13, 2008: Fertility researchers have used DNA fingerprinting for the first time to identify which embryos have implanted after in vitro fertilisation (IVF) and developed successfully to result in the births of healthy babies. The technique, combined with sampling cells from blastocysts (the very early embryo) before implantation in the womb, opens the way to pin-pointing a handful of genes that could be used to identify those blastocysts most likely to result in a successful pregnancy. Read more...
April 1, 2008: Scientists at Newcastle University have created part-human, part-animal hybrid embryos for the first time in the UK. An unfertilized cows egg was cut open by the XYClone laser, and virtually all the genetic material was extracted. DNA derived from a human skin cell was then injected into the egg. By using electric shock, the hybrid embryos started growing. It grew for 3 days to 32 cells. The embryo is 99.9% human and 0.1% cow. They hope to grow them for 6 days to extract the stem cells.
April 1, 2008:
The report included an interview with Dr. Robert Lanza, MD, Chief Scientific Officer at Advanced Cell Technology. During the interview, Dr. Lanza and Ms. Walters discussed a number of Advanced Cell Technology's research platforms including its blastomere program for creating human embryonic stem cell (hESC) lines without impacting the developmental potential of embryos as well as the company's research into developing a universal O negative red blood cell bank using human embryonic stem cell science. Advanced Cell Technologies uses a XYClone laser for their research applications.
April 1, 2008:
The report included an interview with Dr. Robert Lanza, MD, Chief Scientific Officer at Advanced Cell Technology. During the interview, Dr. Lanza and Ms. Walters discussed a number of Advanced Cell Technology's research platforms including its blastomere program for creating human embryonic stem cell (hESC) lines without impacting the developmental potential of embryos as well as the company's research into developing a universal O negative red blood cell bank using human embryonic stem cell science. Advanced Cell Technologies uses a XYClone laser for their research applications. 
Building a Culture of Innovation 
June 28, 2011: "Wow" and "cool" aren't words that would typically be used to describe a medical device, but those are the terms that are bandied around by clinicians and med-tech companies when they hear about Hamilton Thorne's (Beverly, Massachusetts) newly-developed Lykos Laser System application. 
